Download PDF
1 / Pages

Other users also viewed these articles

Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease? Fatih Albayrak; Mustafa Gür; Ahmet Karata¿; Süleyman Serdar Koca; Bünyamin K¿sac¿k;
Reumatol Clin. 2024;20:123-7
The activity of psoriatic arthritis with axial involvement correlates with the PsAID12 Jose Antonio Pinto Tasende; Carlota Laura Iñiguez Ubiaga; Victor Eliseo Quevedo Vila; Luis Fernández Dominguez; Francisco Jose Maceiras Pan; Carlos García Porrúa;
Reumatol Clin. 2024;20:80-3
Osteoporosis in psoriatic arthritis: Risk factors, insufficiency fractures and its association with the disease activity María Paz Martínez-Vidal; Vega Jovani; José Raúl Noguera-Pons; Antonio Álvarez-Cienfuegos;
Reumatol Clin. 2024;20:8-13